amylose
Small moleculeexperimental
Amylose is a polysaccharide made of α-D-glucose units, bonded to each other through α(1→4) glycosidic bonds. It is one of the two components of starch, making up approximately 20–25% of it. Because of its tightly packed helical structure, amylose is more resistant to digestion than other starch molecules and is therefore an important form of resistant starch. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2011 (NCT01437917)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAmylose ↗
- NCATS7TDQ74Y18L ↗
Also known as
- amylose
- amylose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01708694 | N/A | Aug 1, 2012 | University of Vermont |
| NCT01437917 | N/A | Sep 30, 2011 | Government of France, University of Rennes |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of France | Government | 1 | 0 | 1 | 2011 |
| University of Rennes | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Vermont | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1